Article
Single nucleotide polymorphism (SNP)-based loss of heterozygosity (LOH) testing by real time PCR in patients suspect of myeloproliferative disease.
PloS one - 1 Jan 2012
Huijsmans Cornelis J J, Poodt Jeroen, Damen Jan, van der Linden Johannes C, Savelkoul Paul H M, Pruijt Johannes F M, Hilbink Mirrian, Hermans Mirjam H A
Abstract excerpt
During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an oncogene activating mutation, the mutant allele may be further potentiated if the wild-type allele is lost or inactivated. In myeloproliferative neoplasms (MPN) somatic acquisition of JAK2V617F may be followed by LOH resulting in loss of the wild type allele. The occurrence of LOH in MPN and other proliferative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
